Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.

Ichikawa S, Fukuhara N, Yamamoto J, Suzuki M, Nakajima S, Okitsu Y, Kohata K, Onishi Y, Ishizawa K, Kameoka J, Harigae H.

Intern Med. 2010;49(17):1907-10. Epub 2010 Sep 1.

2.

Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.

Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, Inoue M, Kawa K.

Am J Hematol. 2008 Sep;83(9):721-7. doi: 10.1002/ajh.21247.

PMID:
18626884
3.

Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.

Kako S, Izutsu K, Oshima K, Sato H, Kanda Y, Motokura T, Chiba S, Kurokawa M.

Am J Hematol. 2007 Oct;82(10):937-9.

PMID:
17663389
4.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
5.

Improved outcome in adult B-cell acute lymphoblastic leukemia.

Hoelzer D, Ludwig WD, Thiel E, Gassmann W, Löffler H, Fonatsch C, Rieder H, Heil G, Heinze B, Arnold R, Hossfeld D, Büchner T, Koch P, Freund M, Hiddemann W, Maschmeyer G, Heyll A, Aul C, Faak T, Kuse R, Ittel TH, Gramatzki M, Diedrich H, Kolbe K, Fuhr HG, Fischer K, Schadeck-Gressel C, Weiss A, Strohscheer I, Metzner B, Fabry U, Gökbuget N, Völkers B, Messerer D, Uberla K.

Blood. 1996 Jan 15;87(2):495-508.

6.

Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation.

Ito T, Makishima H, Nakazawa H, Kobayashi H, Shimodaira S, Nakazawa Y, Kitano K, Matsuda K, Hidaka E, Ishida F.

Eur J Haematol. 2008 Aug;81(2):107-11. doi: 10.1111/j.1600-0609.2008.01090.x. Epub 2008 May 6.

PMID:
18462253
7.

Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.

Chen YC, Ho CL, Kao WY, Hwang JM, Sheu LF, Chao TY.

Ann Hematol. 2001 Nov;80(11):647-52.

PMID:
11757723
8.

Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.

Ishida F, Ko YH, Kim WS, Suzumiya J, Isobe Y, Oshimi K, Nakamura S, Suzuki R.

Cancer Sci. 2012 Jun;103(6):1079-83. doi: 10.1111/j.1349-7006.2012.02251.x. Epub 2012 Mar 23.

PMID:
22360679
9.

Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.

Fetscher S, Lübbert M, Kanz L, Behringer D, Finke J, Mertelsmann R, Lange W.

Bone Marrow Transplant. 1997 Mar;19(5):527-8.

10.

Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).

Xicoy B, Ribera JM, Esteve J, Brunet S, Sanz MA, Fernández-Abellán P, Feliu E.

Leuk Lymphoma. 2003 Sep;44(9):1541-3. Review.

PMID:
14565657
11.

[Autologous hematopoietic stem cell transplantation followed by oral bexarotene in a patient with advanced mycosis fungoides].

Pérez-Barrio S, Izu R, García-Ruiz JC, Acebo E, Martínez de Lagrán Z, Díaz-Pérez JL.

Actas Dermosifiliogr. 2008 Sep;99(7):560-4. Spanish.

PMID:
18682170
12.

Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.

Schmitz N, Kloess M, Reiser M, Berdel WE, Metzner B, Dorken B, Kneba M, Trumper L, Loeffler M, Pfreundschuh M, Glass B; German High-Grade Non Hodgkin's Lymphoma Study Group (DSHNHL).

Cancer. 2006 Jan 1;106(1):136-45.

PMID:
16331635
13.

Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.

Park JA, Jun KR, Nam SH, Ghim TT.

Int J Hematol. 2013 May;97(5):673-6. doi: 10.1007/s12185-013-1319-7. Epub 2013 Apr 4.

PMID:
23550023
15.

Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.

Mangel J, Buckstein R, Imrie K, Spaner D, Crump M, Tompkins K, Reis M, Perez-Ordonez B, Deodhare S, Romans R, Pennell N, Robinson JB, Hewitt K, Richardson P, Lima A, Pavlin P, Berinstein NL.

Semin Oncol. 2002 Feb;29(1 Suppl 2):56-69. Review.

PMID:
11842390
16.

Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?

Dreger P, von Neuhoff N, Kuse R, Sonnen R, Glass B, Uharek L, Schoch R, Löffler H, Schmitz N.

Br J Cancer. 1998 Jun;77(12):2291-7.

17.

Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.

Tomizawa D, Tabuchi K, Kinoshita A, Hanada R, Kigasawa H, Tsukimoto I, Tsuchida M; Tokyo Children's Cancer Study Group.

Pediatr Blood Cancer. 2007 Aug;49(2):127-32.

PMID:
16807916
18.

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.

Khouri IF, Romaguera J, Kantarjian H, Palmer JL, Pugh WC, Korbling M, Hagemeister F, Samuels B, Rodriguez A, Giralt S, Younes A, Przepiorka D, Claxton D, Cabanillas F, Champlin R.

J Clin Oncol. 1998 Dec;16(12):3803-9.

PMID:
9850025
19.

High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.

Martelli M, Vignetti M, Zinzani PL, Gherlinzoni F, Meloni G, Fiacchini M, De Sanctis V, Papa G, Martelli MF, Calabresi F, Tura S, Mandelli F.

J Clin Oncol. 1996 Feb;14(2):534-42.

PMID:
8636768
20.

Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.

Eckrich MJ, Domm J, Ho R, Whitlock JA, Frangoul H.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1327-8. doi: 10.1002/pbc.22182.

PMID:
19760777
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk